tradingkey.logo
tradingkey.logo
Search

ImmuCell Corp

ICCC
Add to Watchlist
11.210USD
+0.150+1.36%
Close 07-31 16:00ETQuotes delayed by 15 min
101.40MMarket Cap
LossP/E TTM

ICCC Financials

See ImmuCell Corp's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

ImmuCell Corp Earnings Date

Latest Release
Aug 14, 2026
EPS / Forecast
--/--
Revenue / Forecast
--/--
Period
FY2025 Earnings
Revenue(YoY)
27.64M
4.34%
EPS(YoY)
-0.12
56.37%
Analyst Rating
--
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
33.22%0.21
-300.28%-0.12
82.02%-0.02
128.34%0.06
385.22%0.16
139.12%0.06
29.17%-0.09
-10.11%-0.20
81.10%-0.06
31.69%-0.15
---0.12
---0.18
---0.30
---0.22
----
----
----
----
----
----
Revenue
28.39%10.36M
-1.61%7.63M
-8.41%5.51M
17.76%6.44M
11.16%8.07M
52.10%7.75M
11.40%6.01M
54.92%5.47M
110.58%7.26M
30.30%5.10M
12.52%5.40M
-8.51%3.53M
-42.55%3.45M
-28.16%3.91M
-6.88%4.80M
-14.98%3.86M
46.08%6.00M
45.43%5.44M
38.35%5.15M
53.13%4.54M
Net Profit
34.18%1.94M
-653.71%-2.85M
80.08%-139.75K
132.77%501.88K
430.46%1.45M
145.14%514.55K
25.35%-701.69K
-11.01%-1.53M
81.09%-437.87K
31.66%-1.14M
-43.49%-940.00K
-101.67%-1.38M
-551.03%-2.32M
-2349.80%-1.67M
-543.33%-655.08K
-584.82%-684.15K
216.31%513.29K
-60.74%74.13K
145.76%147.76K
118.43%141.11K
Net Margin
4.51%18.75%
-156.67%-3.76%
78.26%-2.54%
127.83%7.79%
397.30%17.94%
129.68%6.64%
32.99%-11.67%
28.34%-27.99%
91.02%-6.03%
47.55%-22.37%
---17.42%
---39.06%
---67.17%
---42.65%
----
----
----
----
----
----
Gross Margin
8.16%44.97%
13.33%41.40%
62.93%42.92%
94.47%43.72%
31.46%41.58%
48.02%36.53%
12.21%26.34%
-23.91%22.48%
262.41%31.63%
-2.71%24.68%
--23.48%
--29.55%
--8.73%
--25.37%
----
----
----
----
----
----
Debt to assets ratio
-11.49%19.73%
-8.45%21.39%
-15.39%20.75%
-22.04%20.97%
-17.37%22.29%
-14.48%23.37%
-11.29%24.53%
10.32%26.90%
5.93%26.97%
19.81%27.32%
--27.65%
--24.38%
--25.46%
--22.81%
----
----
----
----
----
----
Revenue
28.39%10.36M
-1.61%7.63M
-8.41%5.51M
17.76%6.44M
11.16%8.07M
52.10%7.75M
11.40%6.01M
54.92%5.47M
110.58%7.26M
30.30%5.10M
12.52%5.40M
-8.51%3.53M
-42.55%3.45M
-28.16%3.91M
-6.88%4.80M
-14.98%3.86M
46.08%6.00M
45.43%5.44M
38.35%5.15M
53.13%4.54M
Operating profit
76.21%1.97M
-109.33%-57.96K
103.49%20.07K
141.08%569.56K
472.48%1.12M
161.92%621.39K
51.45%-574.89K
-6.29%-1.39M
86.70%-300.05K
38.58%-1.00M
-91.97%-1.18M
-110.74%-1.30M
-495.37%-2.26M
-1223.53%-1.63M
-327.52%-616.79K
-387.23%-619.01K
252.31%570.61K
122.92%145.41K
207.75%271.09K
131.18%215.51K
Net Profit
34.18%1.94M
-653.71%-2.85M
80.08%-139.75K
132.77%501.88K
430.46%1.45M
145.14%514.55K
25.35%-701.69K
-11.01%-1.53M
81.09%-437.87K
31.66%-1.14M
-43.49%-940.00K
-101.67%-1.38M
-551.03%-2.32M
-2349.80%-1.67M
-543.33%-655.08K
-584.82%-684.15K
216.31%513.29K
-60.74%74.13K
145.76%147.76K
118.43%141.11K
Current assets
18.48%18.86M
12.64%16.94M
21.15%16.83M
58.76%17.14M
40.29%15.92M
31.15%15.04M
16.10%13.89M
-1.39%10.79M
-7.35%11.35M
-18.04%11.47M
-27.21%11.96M
-36.83%10.95M
-33.07%12.25M
-13.96%13.99M
2.22%16.43M
11.56%17.33M
54.95%18.30M
33.79%16.26M
61.77%16.08M
37.18%15.53M
Total current liabilities
1.22%3.91M
-9.84%3.98M
-10.48%4.00M
-2.43%4.45M
-7.60%3.87M
5.12%4.41M
34.19%4.47M
8.68%4.56M
9.02%4.18M
36.63%4.20M
22.58%3.33M
67.13%4.19M
63.24%3.84M
21.21%3.07M
25.36%2.71M
23.46%2.51M
12.05%2.35M
14.63%2.53M
20.19%2.17M
-14.47%2.03M
Total assets
-3.32%44.11M
-5.69%42.53M
2.88%45.73M
11.62%46.72M
5.97%45.62M
2.95%45.10M
-0.22%44.45M
-4.89%41.86M
-0.17%43.05M
-2.35%43.81M
-4.00%44.55M
-4.30%44.01M
-7.66%43.12M
0.89%44.86M
4.91%46.40M
5.15%45.98M
17.86%46.70M
10.20%44.47M
10.61%44.23M
7.55%43.73M
Total liabilities
-9.95%14.97M
-11.97%15.48M
-11.69%15.93M
-8.41%16.85M
-9.70%16.63M
-6.55%17.58M
-2.67%18.04M
7.29%18.40M
23.08%18.41M
29.93%18.82M
28.52%18.53M
29.84%17.15M
12.27%14.96M
21.80%14.48M
22.51%14.42M
15.25%13.21M
13.42%13.33M
-1.61%11.89M
-1.65%11.77M
-7.42%11.46M
Total equity
0.49%29.14M
-1.68%27.06M
12.83%29.80M
27.34%29.87M
17.69%28.99M
10.10%27.52M
1.53%26.41M
-12.67%23.46M
-12.52%24.64M
-17.73%24.99M
-18.66%26.01M
-18.06%26.86M
-15.62%28.16M
-6.74%30.38M
-1.48%31.98M
1.57%32.77M
19.74%33.37M
15.25%32.58M
15.85%32.46M
14.10%32.27M
Net operating income
127.03%3.57M
15915.83%482.54K
-84.97%-1.18M
175.28%1.60M
276.06%1.57M
99.58%-3.05K
-25.91%-639.33K
185.38%581.78K
115.15%418.50K
44.29%-723.07K
59.64%-507.75K
-282.46%-681.43K
-532.55%-2.76M
-320.76%-1.30M
-585.75%-1.26M
-48.90%373.46K
202.40%638.53K
276.26%587.89K
138.81%258.99K
-24.59%730.83K
Net investment
49.18%-167.23K
14.73%-167.31K
-569.62%-592.02K
-18.53%-125.93K
-367.69%-329.05K
-680.81%-196.22K
83.42%-88.41K
85.00%-106.24K
89.69%-70.36K
102.27%33.78K
27.38%-533.26K
24.90%-708.41K
14.36%-682.15K
-111.89%-1.49M
-9.37%-734.31K
-7.27%-943.29K
-221.29%-796.50K
-192.99%-703.28K
54.42%-671.42K
65.74%-879.34K
Net financing
0.90%-400.00K
-365.07%-394.60K
-110.51%-337.69K
31.50%-76.45K
-10.12%-403.65K
146.31%148.87K
103.79%3.21M
55.70%-111.60K
-148.96%-366.54K
-29.50%-321.43K
806.48%1.58M
-23.43%-251.90K
-58.17%748.62K
-27.35%-248.21K
-207.45%-223.10K
-105.05%-204.08K
1114.39%1.79M
-127.17%-194.91K
245.03%207.64K
211.96%4.04M

FAQs

What is the total revenue of ImmuCell Corp?

According to ImmuCell Corp's FY2025 earnings report, its total revenue reached 27.64M, with a year-on-year change of 26.49M.

What are the current assets of ImmuCell Corp?

According to ImmuCell Corp's FY2025 earnings report, its current assets were 16.94M, with a year-on-year change of 12.64.

What are the total assets of ImmuCell Corp?

According to ImmuCell Corp's FY2025 earnings report, its total assets of ImmuCell Corp were 42.53M, with a year-on-year change of -5.69.

What are the total liabilities of ImmuCell Corp?

According to ImmuCell Corp's FY2025 earnings report, its total liabilities of ImmuCell Corp were 15.48M, with a year-on-year change of -11.97.

What is the total equity of ImmuCell Corp?

According to ImmuCell Corp's FY2025 earnings report, its total equity of ImmuCell Corp was 27.06M, with a year-on-year change of -1.68.

What is the net operating income of ImmuCell Corp?

According to ImmuCell Corp's FY2025 earnings report, its net operating income of ImmuCell Corp was 1.65M, with a year-on-year change of 200.56.

What is the net investment of ImmuCell Corp?

According to ImmuCell Corp's FY2025 earnings report, its net investment of ImmuCell Corp was -1.21M, with a year-on-year change of -163.28.

What is the net financing of ImmuCell Corp?

According to ImmuCell Corp's FY2025 earnings report, its net financing of ImmuCell Corp was -1.21M, with a year-on-year change of -142.06.

What is the Earnings Per Share (EPS) of ImmuCell Corp?

According to ImmuCell Corp's FY2025 earnings report, its Earnings Per Share (EPS) was -0.12, with a year-on-year change of 56.37.

What is the net income of ImmuCell Corp?

According to ImmuCell Corp's FY2025 earnings report, its net income was -1.04M, with a year-on-year change of 51.78.

What is the net margin of ImmuCell Corp?

According to ImmuCell Corp's FY2025 earnings report, its net profit margin was -3.76, with a year-on-year change of 53.78.

What is the gross margin of ImmuCell Corp?

According to ImmuCell Corp's FY2025 earnings report, its gross margin was 41.40, with a year-on-year change of 38.13.

What is the debt-to-asset ratio of ImmuCell Corp?

According to ImmuCell Corp's FY2025 earnings report, its debt-to-asset ratio was 21.39, with a year-on-year change of -8.45.

What is the Return on Equity (ROE) of ImmuCell Corp?

According to ImmuCell Corp's FY2025 earnings report, its Return on Equity (ROE) was -3.81, with a year-on-year change of 53.60.

What is the Return on Assets (ROA) of ImmuCell Corp?

According to ImmuCell Corp's FY2025 earnings report, its Return on Assets (ROA) was -2.37, with a year-on-year change of 51.07.

What is the operating profit of ImmuCell Corp?

According to ImmuCell Corp's FY2025 earnings report, its operating profit was 1.65M, with a year-on-year change of 200.56.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.